scholarly journals Histological Scoring for Nonalcoholic Fatty Liver Disease – A Study in 55 Cases

2014 ◽  
Vol 14 (2) ◽  
pp. 114-118
Author(s):  
Rehana Khanam ◽  
Muhammad Kamal ◽  
Fauzia Jahan ◽  
P. K. Ghosh

Background: Steatohepatitis is a pattern of liver injury that may be seen in alcoholic or nonalcoholic liver disease. This morphological changes may occur with obesity, diabetes, the use of certain drugs or it may be idiopathic. The main histopathological features of nonalcoholic steatohepatitis (NASH) include hepatocellular steatosis and ballooning, mixed acute and chronic lobular inflammation and fibrosis. The recently developed histological scoring system for NAFLD by the NASH Clinical Research Network (NASH CRN) is becoming increasingly popular. The  purpose of this study was to develop grading andstaging system and was  based on liver biopsies from 50 patients with Nonalcoholic Steatohepatitis from BSMMU and other clinics of Dhaka city.Objective: This study was done to analyze the histological spectrum and to develop grading and staging system in patients with nonalcoholic fatty liver disease.Methods: This cross sectional study was carried out at Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. A total of 55 patients with non-alcoholic fatty liver disease (NAFLD) who fulfilled the inclusion criteria were selected for the study. Liver biopsy was done at hepatology department of BSMMU, and different clinics of the Dhaka City from july 2006 to june 2007. The data of patients along with   histopathological reports were studied.Results: Out of total 55 cases of Nonalcoholic Fatty Liver Disease 33 were male (63.63%) and 22 were female (40%). Mean age of the patient was 37.81±10.80 years. 35 (63.63%) patients were obese. 2 patients (3.63%) were diabetic. Among 55 patients NAFL (steatosis) were diagnosed in 6 patients (10.90%) and NASH in 49 patients (89.09%). Forty two (16.36%) of the 46 Definite NASH biopsy specimen exhibited fibrosis and three had cirrhosis.DOI: http://dx.doi.org/10.3329/jom.v14i2.19638 J Medicine 2013, 14(2): 114-118

Author(s):  
Noel T Mueller ◽  
Tiange Liu ◽  
Elana B Mitchel ◽  
Katherine P Yates ◽  
Ayako Suzuki ◽  
...  

Abstract Context Sex hormones have been linked with presence and severity of nonalcoholic fatty liver disease (NAFLD) in adults, but it is unknown if they affect severity of pediatric NAFLD. Objective To examine associations of circulating SHBG, estrogens, and androgens with key histologic features of pediatric, biopsy-confirmed NAFLD. Design Baseline assessment of longitudinal cohorts and randomized clinical trials. Setting Nonalcoholic Steatohepatitis Clinical Research Network. Patients Children and adolescents ≤18 years with liver biopsy-confirmed NAFLD in the United States. Main Outcome Measures We assayed SHBG, estrone, estradiol, dehydroepiandrosterone (DHEAS), androstenedione, and testosterone in relation to grade/stage of steatosis, portal inflammation, hepatic ballooning, fibrosis, and nonalcoholic steatohepatitis (NASH) severity using linear regression. Results Mean age of 573 children at the time of biopsy was 13.1 years (SD 2.8). Lower SHBG was inversely associated with steatosis severity in boys and girls (P = 0.001), and with portal inflammation in girls only (P for sex interaction <0.001). Higher testosterone was related to improved features of steatosis and fibrosis (P for sex interaction = 0.003 and 0.01, respectively) in boys, but detrimental in girls. In boys and girls, higher estrone, estradiol, and testosterone were associated with lower portal inflammation grade; higher estradiol was positively associated with hepatic ballooning severity; DHEAS was inversely associated with hepatic ballooning and NASH severity (all P < 0.05). Androstenedione was not associated with NAFLD features. Conclusions Largely consistent with findings in adults, sex hormones are associated with distinct histologic features of NAFLD in children and adolescents. These hormone levels relate to differences with gender and pubertal change.


2016 ◽  
Vol 67 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Michiie Sakamoto ◽  
Hanako Tsujikawa ◽  
Kathryn Effendi ◽  
Hidenori Ojima ◽  
Kenichi Harada ◽  
...  

2021 ◽  
Vol 15 (12) ◽  
pp. 3241-3243
Author(s):  
Azhar Hussain ◽  
Mehwish Iftikhar ◽  
Amna Rizvi ◽  
Muhammad Latif ◽  
Muhammad Javed Ahmed ◽  
...  

Background: SARS-CoV-2 principally invades the respiratory system. ACE receptor are also abundant throughout the hepatobiliary system and their increased expression on hepatocyte make patients with NAFLD more vulnerable. Aim: To see outcomes of COVID positive diabetic patients suffering from Nonalcoholic fatty liver disease (NAFLD). Study design: Cross Sectional Study. Methodology: 150 diabetic and COVID PCR positive were recruited from COVID ward of Services Hospital in Lahore. Clinical parameters like BMI, SpO2, Hepatomegaly and lab parameters like HbA1C, AST ALT were noted in spreadsheet. Statistical analysis was done using SPSS v.25. Statistical significance for difference in proportions is calculated using Pearson’s Chi-Squared test. P less than 0.05 was considered statistically significant. Results: Around 84(56%) were males and 66(44%) females, smoked were 27(18%), mean age (years) was 59.7333 ±11.35023, mean BMI (kg/m²) was 30.1425±7.30673, 87(58%) patients had NAFLD, who experienced sever disease (53.2%; x^2=0.010) and more mortalities (60.2%;x^2=0.453) as compared to those who do not had condition. Conclusion: We concluded that NAFLD makes COVID-19 infected patients more fragile. Such patients experienced sever disease and more mortalities however need of mechanical ventilation remains almost equal between those who has NAFLD and those who didn’t had. Keywords: Nonalcoholic fatty liver disease, COVID-19, Diabetes, Mortality and Severity.


Sign in / Sign up

Export Citation Format

Share Document